Phenominer Database Results (35 results)

 

How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Site Method Duration Post Insult Type Post Insult Time Value Post Insult Time Unit Method Notes Clinical Measurement Notes Record ID Study ID
F344.GK-(D1Arb42a-D1Rat90)/Swe body weight control condition (for 65 days) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. body mass male 65 days 11 197.0 g 5.0 16.58 body weighing method 0.0 0 11464 85
F344.GK-(D1Arb42a-D1Rat90)/Swe body weight control condition (for 185 days) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. body mass male 185 days 10 35.0 g 6.0 18.97 body weighing method 0.0 0 11485 85
F344.GK-(D1Arb42a-D1Rat90)/Swe blood glucose level fasting (for 6 hours) then glucose solution (2 g/kg) Granhall C, et al., Genetics. 2006 Nov;174(3):1565-72. Epub 2006 Sep 1. blood glucose amount male 95 days 12 367.2 mg/dl 9.0 31.18 intraperitoneal glucose tolerance test tail vein post glucose injection 15 min 13091 330
F344.GK-(D1Arb42a-D1Rat90)/Swe serum insulin level fasting (between 6 and 7 hours) then glucose solution (2 g/kg) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood insulin amount male 95 days 11 0.01 mg/dl 0.0 0.01 intraperitoneal glucose tolerance test tail vein 0.0 post glucose injection 0 min 67631 85
F344.GK-(D1Arb42a-D1Rat90)/Swe serum insulin level fasting (between 6 and 7 hours) then glucose solution (2 g/kg) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood insulin amount male 65 days 11 0.0 mg/dl 0.0 0.0 intraperitoneal glucose tolerance test tail vein 0.0 post glucose injection 0 min 67622 85
F344.GK-(D1Arb42a-D1Rat90)/Swe beta cell area to total pancreatic islet area ratio control condition Granhall C, et al., Diabetes. 2006 Dec;55(12):3494-500. pancreatic beta cell morphology trait male 60 days 3 61.8 % 1.2 2.08 ex vivo light microscopy with digital image analysis 0.0 0 67461 333
F344.GK-(D1Arb42a-D1Rat90)/Swe blood glucose level fasting (between 6 and 7 hours) then glucose solution (2 g/kg) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood glucose amount male 65 days 11 309.6 mg/dl 9.0 29.85 intraperitoneal glucose tolerance test tail vein post glucose injection 15 min Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) 11462 85
F344.GK-(D1Arb42a-D1Rat90)/Swe blood glucose level fasting (between 6 and 7 hours) then glucose solution (2 g/kg) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood glucose amount male 65 days 11 88.2 mg/dl 1.8 5.97 intraperitoneal glucose tolerance test tail vein post glucose injection 60 min Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) 11455 85
F344.GK-(D1Arb42a-D1Rat90)/Swe serum total cholesterol level fasting (between 6 and 7 hours) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood cholesterol amount male 185 days 10 89.19 mg/dl 3.09 9.77 serum total cholesterol measurement test tail vein 0 Vitros CHOL slides (Johnson & Johnson, Rochester, NY) 11477 85
F344.GK-(D1Arb42a-D1Rat90)/Swe pancreatic islet area to total pancreatic area ratio control condition Granhall C, et al., Diabetes. 2006 Dec;55(12):3494-500. islet of Langerhans morphology trait male 60 days 3 1.27 % 0.13 0.23 ex vivo light microscopy with digital image analysis pancreas 0.0 0 67180 333
F344.GK-(D1Arb42a-D1Rat90)/Swe blood glucose level fasting (for 6 hours) then glucose solution (2 g/kg) Granhall C, et al., Genetics. 2006 Nov;174(3):1565-72. Epub 2006 Sep 1. blood glucose amount male 95 days 12 297.0 mg/dl 12.6 43.65 intraperitoneal glucose tolerance test tail vein post glucose injection 30 min 13092 330
F344.GK-(D1Arb42a-D1Rat90)/Swe blood glucose level fasting (between 6 and 7 hours) then glucose solution (2 g/kg) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood glucose amount male 65 days 11 84.6 mg/dl 1.8 5.97 intraperitoneal glucose tolerance test tail vein 0.0 post glucose injection 0 min Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) 11449 85
F344.GK-(D1Arb42a-D1Rat90)/Swe blood glucose level fasting (between 6 and 7 hours) then glucose solution (2 g/kg) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood glucose amount male 95 days 11 104.4 mg/dl 3.6 11.94 intraperitoneal glucose tolerance test tail vein post glucose injection 0 min Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) 11430 85
F344.GK-(D1Arb42a-D1Rat90)/Swe blood glucose level area under curve (AUC) fasting (between 6 and 7 hours) then glucose solution (2 g/kg) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood glucose amount male 65 days 11 13600.0 (mg/dl) x min 327.27 1085.44 intraperitoneal glucose tolerance test tail vein post glucose injection 90 min Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) 11468 85
F344.GK-(D1Arb42a-D1Rat90)/Swe blood glucose level fasting (between 6 and 7 hours) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood glucose amount male 185 days 10 102.6 mg/dl 1.8 5.69 blood glucose analysis tail vein 0 Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) 11480 85
F344.GK-(D1Arb42a-D1Rat90)/Swe blood insulin level fasting (for 6 hours) then glucose solution (2 g/kg) Granhall C, et al., Genetics. 2006 Nov;174(3):1565-72. Epub 2006 Sep 1. blood insulin amount male 95 days 12 136.25 mU/l 14.86 51.49 intraperitoneal glucose tolerance test tail vein post glucose injection 15 min micrograms/L 13089 330
F344.GK-(D1Arb42a-D1Rat90)/Swe serum insulin level fasting (between 6 and 7 hours) then glucose solution (2 g/kg) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood insulin amount male 65 days 11 0.03 mg/dl 0.0 0.01 intraperitoneal glucose tolerance test tail vein 0.0 post glucose injection 15 min 67626 85
F344.GK-(D1Arb42a-D1Rat90)/Swe serum insulin level fasting (between 6 and 7 hours) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood insulin amount male 185 days 10 0.03 mg/dl 0.0 0.01 enzyme linked immunosorbent assay tail vein 0.0 0 67645 85
F344.GK-(D1Arb42a-D1Rat90)/Swe pancreas insulin level to pancreas total protein ratio control condition Granhall C, et al., Diabetes. 2006 Dec;55(12):3494-500. pancreas insulin amount male 60 days 6 231.0 ng/mg 18.0 44.09 enzyme linked immunosorbent assay 0.0 0 68145 333
F344.GK-(D1Arb42a-D1Rat90)/Swe serum insulin level fasting (between 6 and 7 hours) then glucose solution (2 g/kg) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood insulin amount male 95 days 11 0.05 mg/dl 0.01 0.04 intraperitoneal glucose tolerance test tail vein 0.0 post glucose injection 15 min 67635 85
F344.GK-(D1Arb42a-D1Rat90)/Swe blood glucose level fasting (between 6 and 7 hours) then glucose solution (2 g/kg) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood glucose amount male 65 days 11 189.0 mg/dl 7.2 23.88 intraperitoneal glucose tolerance test tail vein post glucose injection 30 min Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) 11459 85
F344.GK-(D1Arb42a-D1Rat90)/Swe blood glucose level fasting (between 6 and 7 hours) then glucose solution (2 g/kg) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood glucose amount male 65 days 11 86.4 mg/dl 3.6 11.94 intraperitoneal glucose tolerance test tail vein 0.0 post glucose injection 90 min Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) 11453 85
F344.GK-(D1Arb42a-D1Rat90)/Swe serum triglyceride level fasting (between 6 and 7 hours) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood triglyceride amount male 185 days 10 191.15 mg/dl 12.39 39.18 serum triglyceride analysis tail vein 0 Vitros TRIG slides (Johnson & Johnson, Rochester, NY) 11474 85
F344.GK-(D1Arb42a-D1Rat90)/Swe blood glucose level area under curve (AUC) fasting (between 6 and 7 hours) then glucose solution (2 g/kg) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood glucose amount male 95 days 11 18200.0 (mg/dl) x min 509.09 1688.46 intraperitoneal glucose tolerance test tail vein post glucose injection 90 min Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) 11448 85
F344.GK-(D1Arb42a-D1Rat90)/Swe serum insulin level fasting (between 6 and 7 hours) then glucose solution (2 g/kg) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood insulin amount male 95 days 11 0.05 mg/dl 0.01 0.04 intraperitoneal glucose tolerance test tail vein 0.0 post glucose injection 30 min 67638 85
F344.GK-(D1Arb42a-D1Rat90)/Swe blood glucose level fasting (between 6 and 7 hours) then glucose solution (2 g/kg) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood glucose amount male 95 days 11 333.0 mg/dl 14.4 47.76 intraperitoneal glucose tolerance test tail vein post glucose injection 15 min Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) 11442 85
F344.GK-(D1Arb42a-D1Rat90)/Swe blood glucose level fasting (between 6 and 7 hours) then glucose solution (2 g/kg) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood glucose amount male 95 days 11 252.0 mg/dl 7.2 23.88 intraperitoneal glucose tolerance test tail vein post glucose injection 30 min Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) 11438 85
F344.GK-(D1Arb42a-D1Rat90)/Swe body weight fasting (for 6 hours) Granhall C, et al., Genetics. 2006 Nov;174(3):1565-72. Epub 2006 Sep 1. body mass male 95 days 24 286.0 g 3.0 14.7 body weighing method 0 0 13088 330
F344.GK-(D1Arb42a-D1Rat90)/Swe epididymal fat pad weight control condition Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. epididymal fat pad mass male 185 days 10 10.2 g 0.4 1.26 post excision weight measurement 0 11482 85
F344.GK-(D1Arb42a-D1Rat90)/Swe blood glucose level fasting (between 6 and 7 hours) then glucose solution (2 g/kg) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood glucose amount male 95 days 11 129.6 mg/dl 3.6 11.94 intraperitoneal glucose tolerance test tail vein post glucose injection 90 min Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) 11433 85
F344.GK-(D1Arb42a-D1Rat90)/Swe pancreas wet weight control condition Granhall C, et al., Diabetes. 2006 Dec;55(12):3494-500. pancreas mass male 60 days 6 0.91 g 0.02 0.06 post excision weight measurement 0 13186 333
F344.GK-(D1Arb42a-D1Rat90)/Swe body weight control condition (for 95 days) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. body mass male 95 days 11 27.0 g 6.0 19.9 body weighing method 0.0 0 11443 85
F344.GK-(D1Arb42a-D1Rat90)/Swe blood glucose level fasting (between 6 and 7 hours) then glucose solution (2 g/kg) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood glucose amount male 95 days 11 153.0 mg/dl 5.4 17.91 intraperitoneal glucose tolerance test tail vein post glucose injection 60 min Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) 11436 85
F344.GK-(D1Arb42a-D1Rat90)/Swe serum insulin level fasting (between 6 and 7 hours) then glucose solution (2 g/kg) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood insulin amount male 65 days 11 0.02 mg/dl 0.0 0.01 intraperitoneal glucose tolerance test tail vein 0.0 post glucose injection 30 min 67629 85
F344.GK-(D1Arb42a-D1Rat90)/Swe serum high density lipoprotein cholesterol level fasting (between 6 and 7 hours) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. blood HDL cholesterol amount male 185 days 10 41.7 mg/dl 1.54 4.88 serum high-density lipoprotein-cholesterol measurement test tail vein 0 N-geneous HDL-c kit (Biomed-RK, Jonkoping, Sweden) 11472 85